On Wednesday shares of Skyworks Solutions Inc. (NASDAQ:SWKS) closed at $95.57. Company’s sales growth for last 5 years was 23.30% and EPS growth for next 5 years is recorded as 20.62%. Skyworks Solutions (NASDAQ:SWKS) was downgraded by Zacks from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Tuesday. They currently have a $114.00 price target on the stock.Zacks‘s target price would suggest a potential upside of 12.36% from the stock’s previous close.
Vascular Biogenics Ltd. (NASDAQ:VBLT) in last trading activity advanced 29.16% to close at $7.22. Company weekly performance is 113.61% while its quarterly performance stands at 21.75%. Vascular Biogenics Ltd. (NASDAQ:VBLT) is -57.58% away from its 52 week high. Vascular Biogenics Ltd. (NASDAQ:VBLT) announced Wednesday morning that its Phase 2 study of VB-111, in patients with recurrent glioblastoma, demonstrated a statistically significant improvement in overall survival in patients treated with VB-111 followed by VB-111 in combination with bevacizumab upon disease progression, compared to patients treated with VB-111 followed by bevacizumab alone upon disease progression.
On last trading day First Midwest Bancorp Inc. (NASDAQ:FMBI) decreased -2.25% to close at $16.98. Its volatility for the week is 1.94% while volatility for the month is 1.87%. FMBI’s sales growth for past 5 years was -2.60% and its EPS growth for past 5 years was 26.90%. First Midwest Bancorp Inc. (NASDAQ:FMBI) monthly performance is -1.16%. First Midwest Bancorp Inc. (NASDAQ:FMBI) cash dividend payment of $0.09 per share is scheduled to be paid on April 14, 2015. Shareholders who purchased FMBI prior to the ex-dividend date are eligible for the cash dividend payment.
On Wednesday shares of Caterpillar Inc. (NYSE:CAT) closed at $79.86. Company’s sales growth for last 5 years was 11.20% and EPS growth for next 5 years is recorded as 9.69%. On March 21, Caterpillar Inc. (NYSE:CAT) said that it will move two production lines from its Joliet plant to Mexico in a plan that will result in the loss of 230 jobs at the Illinois site. The (Joliet) Herald-News reports that the company made the announcement Friday. The construction and mining equipment maker said in a statement that it was pushing ahead with the plan in order to “remain cost competitive.”
On last trading day Cara Therapeutics Inc. (NASDAQ:CARA) decreased -5.24% to close at $9.59. Its volatility for the week is 6.46% while volatility for the month is 5.09%. Cara Therapeutics Inc. (NASDAQ:CARA) monthly performance is -10.54%. Cara Therapeutics, Inc. (NASDAQ:CARA) announced that the Company will host a conference call and live audio webcast on Thursday, March 26, 2015, at 4:30 p.m. ET to report fourth quarter and full year 2014 financial results and provide a corporate update.